Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Finasteride effectively treats male hair loss, improving growth and density.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Both genetic and lifestyle factors significantly affect female hair loss.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.